West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems … Read more
West Pharmaceutical Services Inc (WST) - Total Liabilities
Latest total liabilities as of March 2025: $935.10 Million USD
Based on the latest financial reports, West Pharmaceutical Services Inc (WST) has total liabilities worth $935.10 Million USD as of March 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
West Pharmaceutical Services Inc - Total Liabilities Trend (1985–2024)
This chart illustrates how West Pharmaceutical Services Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
West Pharmaceutical Services Inc Competitors by Total Liabilities
The table below lists competitors of West Pharmaceutical Services Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Cathay Financial Holding Co Ltd Pref A
TW:2882A
|
Taiwan | NT$12.98 Trillion |
|
Metro Inc
PINK:MTRAF
|
USA | $7.16 Billion |
|
Banco De Chile
NYSE:BCH
|
USA | $48.37 Trillion |
|
Tyson Foods Inc
NYSE:TSN
|
USA | $17.88 Billion |
|
Curtiss-Wright Corporation
NYSE:CW
|
USA | $2.39 Billion |
|
Ecopetrol S.A
F:ECHA
|
Germany | €192.33 Trillion |
|
Expeditors International of Washington, Inc.
NASDAQ:EXPD
|
USA | $2.47 Billion |
|
News Corp B
NASDAQ:NWS
|
USA | $1.32 Billion |
Liability Composition Analysis (1985–2024)
This chart breaks down West Pharmaceutical Services Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.77 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.35 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.26 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how West Pharmaceutical Services Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for West Pharmaceutical Services Inc (1985–2024)
The table below shows the annual total liabilities of West Pharmaceutical Services Inc from 1985 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $961.10 Million | +1.33% |
| 2023-12-31 | $948.50 Million | +1.78% |
| 2022-12-31 | $931.90 Million | -4.75% |
| 2021-12-31 | $978.40 Million | +4.16% |
| 2020-12-31 | $939.30 Million | +22.27% |
| 2019-12-31 | $768.20 Million | +291.74% |
| 2018-12-31 | $196.10 Million | -0.46% |
| 2017-12-31 | $197.00 Million | -13.82% |
| 2016-12-31 | $228.60 Million | -23.34% |
| 2015-12-31 | $298.20 Million | -11.43% |
| 2014-12-31 | $336.70 Million | -56.00% |
| 2013-12-31 | $765.20 Million | -8.37% |
| 2012-12-31 | $835.10 Million | +12.21% |
| 2011-12-31 | $744.20 Million | +11.31% |
| 2010-12-31 | $668.60 Million | -3.37% |
| 2009-12-31 | $691.90 Million | +1.51% |
| 2008-12-31 | $681.60 Million | -1.89% |
| 2007-12-31 | $694.70 Million | +39.25% |
| 2006-12-31 | $498.90 Million | +2.65% |
| 2005-12-31 | $486.00 Million | +35.91% |
| 2004-12-31 | $357.60 Million | -2.30% |
| 2003-12-31 | $366.00 Million | +9.16% |
| 2002-12-31 | $335.30 Million | +0.24% |
| 2001-12-31 | $334.50 Million | -4.86% |
| 2000-12-31 | $351.60 Million | +9.94% |
| 1999-12-31 | $319.80 Million | +16.33% |
| 1998-12-31 | $274.90 Million | +37.59% |
| 1997-12-31 | $199.80 Million | -11.24% |
| 1996-12-31 | $225.10 Million | -0.31% |
| 1995-12-31 | $225.80 Million | +34.24% |
| 1994-12-31 | $168.20 Million | +55.17% |
| 1993-12-31 | $108.40 Million | -13.76% |
| 1992-12-31 | $125.70 Million | -17.36% |
| 1991-12-31 | $152.10 Million | -2.31% |
| 1990-12-31 | $155.70 Million | +25.36% |
| 1989-12-31 | $124.20 Million | -2.59% |
| 1988-12-31 | $127.50 Million | +2.57% |
| 1987-12-31 | $124.30 Million | +26.19% |
| 1986-12-31 | $98.50 Million | +65.55% |
| 1985-12-31 | $59.50 Million | -- |